K
Kook Soon Dang Co Ltd
KOSDAQ:043650
Kook Soon Dang Co Ltd
KOSDAQ:043650
Price:
3 595
KRW
-2.04%
Market Closed
Market Cap:
64.2B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Kook Soon Dang Co Ltd
3595
-75 (-2.04%)
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Kook Soon Dang Co Ltd
Balance Sheet
Balance Sheet Decomposition
Kook Soon Dang Co Ltd
Kook Soon Dang Co Ltd
| Current Assets | 89.7B |
| Cash & Short-Term Investments | 44.8B |
| Receivables | 13.7B |
| Other Current Assets | 31.2B |
| Non-Current Assets | 155.1B |
| Long-Term Investments | 101.4B |
| PP&E | 45.7B |
| Intangibles | 3.6B |
| Other Non-Current Assets | 4.5B |
| Current Liabilities | 9B |
| Accounts Payable | 2.6B |
| Accrued Liabilities | 1.5B |
| Other Current Liabilities | 4.9B |
| Non-Current Liabilities | 10.8B |
| Long-Term Debt | 293.9m |
| Other Non-Current Liabilities | 10.6B |
Balance Sheet
Kook Soon Dang Co Ltd
Kook Soon Dang Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
37 463
|
37 752
|
24 731
|
36 745
|
24 842
|
33 928
|
39 771
|
37 370
|
44 927
|
36 083
|
|
| Cash |
37 463
|
37 752
|
24 731
|
36 745
|
24 842
|
11
|
2
|
1
|
1
|
1
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
33 917
|
39 769
|
37 370
|
44 925
|
36 082
|
|
| Short-Term Investments |
27 587
|
26 352
|
24 440
|
10 719
|
17 693
|
4 799
|
3 826
|
9 956
|
19 171
|
8 691
|
|
| Total Receivables |
13 753
|
13 157
|
15 943
|
19 147
|
9 949
|
14 239
|
11 041
|
10 587
|
10 336
|
13 652
|
|
| Accounts Receivables |
12 223
|
12 477
|
9 781
|
8 000
|
6 231
|
6 369
|
6 399
|
7 323
|
7 389
|
6 316
|
|
| Other Receivables |
1 530
|
680
|
6 162
|
11 147
|
3 718
|
7 870
|
4 642
|
3 265
|
2 947
|
7 336
|
|
| Inventory |
15 333
|
14 870
|
14 890
|
14 499
|
14 889
|
14 782
|
12 081
|
14 638
|
17 087
|
19 298
|
|
| Other Current Assets |
5 156
|
5 091
|
5 257
|
5 905
|
5 534
|
5 800
|
6 564
|
7 656
|
10 504
|
11 951
|
|
| Total Current Assets |
99 292
|
97 221
|
85 261
|
87 014
|
72 907
|
73 547
|
73 282
|
80 208
|
102 024
|
89 674
|
|
| PP&E Net |
72 019
|
69 161
|
64 895
|
58 233
|
66 740
|
54 678
|
51 422
|
45 156
|
44 841
|
45 676
|
|
| PP&E Gross |
72 019
|
69 161
|
64 895
|
58 233
|
66 740
|
54 678
|
51 422
|
45 156
|
44 841
|
45 676
|
|
| Accumulated Depreciation |
41 828
|
43 743
|
47 896
|
49 651
|
44 295
|
48 933
|
48 023
|
45 426
|
47 271
|
48 725
|
|
| Intangible Assets |
4 307
|
3 523
|
3 119
|
2 681
|
3 146
|
3 612
|
3 388
|
3 426
|
3 405
|
3 617
|
|
| Note Receivable |
1 221
|
1 084
|
838
|
626
|
2 322
|
110
|
109
|
338
|
580
|
661
|
|
| Long-Term Investments |
38 880
|
42 648
|
54 696
|
90 410
|
92 129
|
93 310
|
115 680
|
137 098
|
101 960
|
101 357
|
|
| Other Long-Term Assets |
1 760
|
2 950
|
4 196
|
3 664
|
1 375
|
1 198
|
1 002
|
940
|
1 036
|
3 811
|
|
| Total Assets |
217 480
N/A
|
216 588
0%
|
213 005
-2%
|
242 629
+14%
|
238 619
-2%
|
226 455
-5%
|
244 883
+8%
|
267 165
+9%
|
253 846
-5%
|
244 796
-4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2 058
|
2 243
|
1 884
|
2 452
|
1 424
|
1 747
|
1 313
|
2 812
|
2 455
|
2 596
|
|
| Accrued Liabilities |
2 044
|
1 503
|
1 520
|
1 378
|
1 116
|
1 456
|
1 530
|
2 267
|
2 247
|
1 496
|
|
| Short-Term Debt |
0
|
0
|
300
|
520
|
490
|
820
|
306
|
309
|
93
|
0
|
|
| Current Portion of Long-Term Debt |
690
|
0
|
660
|
0
|
440
|
296
|
527
|
540
|
470
|
382
|
|
| Other Current Liabilities |
9 427
|
6 995
|
6 422
|
7 896
|
8 313
|
4 233
|
7 730
|
7 037
|
7 474
|
4 502
|
|
| Total Current Liabilities |
14 219
|
10 741
|
10 786
|
12 246
|
11 783
|
8 552
|
11 407
|
12 964
|
12 739
|
8 977
|
|
| Long-Term Debt |
220
|
660
|
0
|
1 140
|
700
|
1 412
|
882
|
0
|
462
|
294
|
|
| Deferred Income Tax |
750
|
1 005
|
946
|
1 300
|
2 533
|
564
|
4 628
|
4 902
|
153
|
0
|
|
| Minority Interest |
4 747
|
4 982
|
4 545
|
4 386
|
3 665
|
4 291
|
1 858
|
2 024
|
2 095
|
2 117
|
|
| Other Liabilities |
5 480
|
6 015
|
7 254
|
6 494
|
7 923
|
6 571
|
5 464
|
6 477
|
6 140
|
8 437
|
|
| Total Liabilities |
25 416
N/A
|
23 403
-8%
|
23 532
+1%
|
25 566
+9%
|
26 604
+4%
|
21 390
-20%
|
24 239
+13%
|
26 367
+9%
|
21 589
-18%
|
19 825
-8%
|
|
| Equity | |||||||||||
| Common Stock |
8 929
|
8 929
|
8 929
|
8 929
|
8 929
|
8 929
|
8 929
|
8 929
|
8 929
|
8 929
|
|
| Retained Earnings |
163 630
|
159 330
|
155 909
|
164 583
|
178 367
|
174 638
|
192 054
|
210 995
|
202 676
|
194 498
|
|
| Additional Paid In Capital |
22 139
|
22 139
|
22 139
|
22 139
|
22 139
|
22 139
|
22 139
|
22 139
|
22 139
|
22 139
|
|
| Unrealized Security Profit/Loss |
243
|
936
|
642
|
19 568
|
734
|
448
|
2 301
|
3 504
|
3 262
|
4 154
|
|
| Treasury Stock |
6 264
|
1 970
|
1 962
|
1 958
|
1 954
|
4 887
|
8 560
|
8 560
|
8 560
|
8 560
|
|
| Other Equity |
3 387
|
3 822
|
3 816
|
3 802
|
3 800
|
3 798
|
3 781
|
3 791
|
3 810
|
3 812
|
|
| Total Equity |
192 064
N/A
|
193 185
+1%
|
189 473
-2%
|
217 063
+15%
|
212 015
-2%
|
205 065
-3%
|
220 644
+8%
|
240 799
+9%
|
232 257
-4%
|
224 972
-3%
|
|
| Total Liabilities & Equity |
217 480
N/A
|
216 588
0%
|
213 005
-2%
|
242 629
+14%
|
238 619
-2%
|
226 455
-5%
|
244 883
+8%
|
267 165
+9%
|
253 846
-5%
|
244 796
-4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
17
|
18
|
18
|
18
|
18
|
17
|
16
|
16
|
16
|
16
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
